Bruker Corporation — Company profile
Healthcare · Medical Devices · United States
Last price 62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.45B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Details
| Name | Bruker Corporation |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 11085 |
| Founded | 1960 |
| Ipo Date | 2000-08-04 |
| Ceo | Frank Laukien |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US1167941087 |
| Cusip | 116794108 |
| Cik | 0001109354 |
| Sic | 3826 |
Key executives
| Name | Title |
|---|---|
| Dr. Burkhard Prause Ph.D. | President and Chief Executive Officer of Bruker Energy and Supercon Technologies, Inc. |
| Dr. Frank H. Laukien Ph.D. | Chairman, Chief Executive Officer and President |
| Gerald N. Herman CPA | Executive Vice President and Chief Financial Officer |
| Dr. Mark R. Munch Ph.D. | Corporate Executive Vice President and President of Bruker Nano Group and Corporate |
| Juergen W. Srega | President of Bruker Biosystems Group and Bruker Daltonics Division |
| Thomas M. Bures | Chief Accounting Officer |
| J. Brent Alldredge J.D. | Senior Vice President, General Counsel, Secretary and Global Head of Compliance |
| Dr. Wolfgang Pusch Ph.D. | President of Bruker Microbiology and Infection Diagnostics Group |
Contact
| Address | 40 Manning Road, Billerica, Massachusetts 01821, United States |
| Phone | 978 663 3660 |
| Website | https://www.bruker.com |